CCL16 and hepatocellular carcinoma: Specific signaling axes such as PI3K-AKT-SELE/VCAM1 and CCL16-CCR1 have been implicated in TAM recruitment in pancreatic ductal adenocarcinoma and hepatocellular carcinoma (HCC),respectively [23, 24].